Showing results (101-110 of 122) with videos related to
Sort By:
Pageof 13
Immunology Letters|July 1, 1988
Brain norepinephrine levels after BCG stimulation of the immune systemP Barneoud, J M Rivet, S Vitiello, et al.Brain Research|May 25, 2005
In mice, production of plasma IL-1 and IL-6 in response to MPTP is related to behavioral lateralizationYan-Qin Shen, Guillaume Hebert, Yun Su, et al.Cancer Research|March 15, 1988
Expression of the c-raf protooncogene, gamma-glutamyltranspeptidase, and gap junction protein in rat liver neoplasmsD G Beer, M J Neveu, D L Paul, et al.Brain Research Bulletin|December 31, 2003
Chronic psychosocial stress down-regulates central cytokines mRNAAlessandro Bartolomucci, Paola Palanza, Stefano Parmigiani, et al.Psychoneuroendocrinology|October 5, 2001
Association between immune activation and early depressive symptoms in cancer patients treated with interleukin-2-based therapyL Capuron, A Ravaud, N Gualde, et al.Brain Research|September 25, 1989
Functional brain asymmetry and murine systemic lupus erythematosusP J Neveu, C Betancur, P Barnéoud, et al.Neuroscience|January 1, 1995
Paw preference and brain dopamine asymmetriesS Cabib, F R D'Amato, P J Neveu, et al.Neuroscience|February 8, 2003
Brain interleukin asymmetries and paw preference in miceQ L Fu, Y Q Shen, M X Gao, et al.Brain Research|May 21, 1990
The nucleus basalis is involved in brain modulation of the immune system in ratsJ Cherkaoui, W Mayo, P J Neveu, et al.Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 20, 2000
Lowered serum dipeptidyl peptidase IV activity is associated with depressive symptoms and cytokine production in cancer patients receiving interleukin-2-based immunotherapyM Maes, L Capuron, A Ravaud, et al.Pageof 13